Quantum Biopharma (QNTM) Minority Interest (2023 - 2026)
Quantum Biopharma (QNTM) posted Minority Interest of -$2.0 million for Q1 2026, down 10.61% sequentially from -$1.8 million in Q4 2025, and down 67.44% YoY from -$6.2 million in Q1 2025.
Quantum Biopharma (QNTM) Minority Interest (2023 - 2026) Analysis & Trends
Quantum Biopharma has reported Minority Interest for 4 years, with the latest figure at -$2.0 million in Q1 2026.
- Quarterly Minority Interest fell 67.44% year-over-year to -$2.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$2.0 million (down 67.44% YoY) and the FY2025 annual result came in at -$1.8 million, down 75.13% from the prior year.
- Minority Interest fell to -$2.0 million in Q1 2026 per QNTM's latest filing, from -$1.8 million in the prior quarter.
- Over five years, Minority Interest peaked at -$89526.0 in Q3 2023 and troughed at -$2.0 million in Q1 2026.
- A 4-year average of -$1.2 million and a median of -$1.1 million in 2025 frame the typical range for Minority Interest.
- The sharpest annual moves came in 2024 and 2025: Minority Interest plunged 954.77% in 2024, then retreated 21.29% in 2025.
- Over 4 years, Minority Interest stood at -$89526.0 in 2023, then tumbled by 1062.02% to -$1.0 million in 2024, then tumbled by 75.13% to -$1.8 million in 2025, then declined by 10.61% to -$2.0 million in 2026.
- According to Business Quant data, Minority Interest over the past three periods registered -$2.0 million, -$1.8 million, and -$1.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Quantum Biopharma | 15.44 Mn | 11.80 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2.02 Mn |
| Dec 31, 2025 | -1.82 Mn |
| Sep 30, 2025 | -1.15 Mn |
| Jun 30, 2025 | -1.72 Mn |
| Mar 31, 2025 | -1.20 Mn |
| Dec 31, 2024 | -1.04 Mn |
| Sep 30, 2024 | -944,291.00 |
| Jun 30, 2024 | -756,134.00 |
| Sep 30, 2023 | -89,526.00 |